← Back to Search

Palliative Care Delivery Methods for Advanced Cancer

N/A
Waitlist Available
Led By Lisa Zubkoff, PhD
Research Sponsored by University of Rochester NCORP Research Base
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
CAREGIVERS: English-speaking as not all caregiver measures have been validated in other languages.
PATIENTS: Diagnosed within the last 90 days with an advanced cancer (defined as a newly diagnosed stage III/IV, recurrence, or progressive solid tumor cancer).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks, 24 weeks
Awards & highlights

Study Summary

This trial is studying two different methods of delivering the ENABLE palliative care program to patients with advanced cancer and their caregivers. The focus of the ENABLE palliative care program is on living well, managing stress, patient communication of their personal values and hopes for care, social support, and symptom management.

Who is the study for?
This trial is for patients recently diagnosed with advanced stage III/IV cancer and their caregivers. Participants must speak English, have telephone access, be able to consent, and not have received prior palliative care services. Caregivers are unpaid friends or relatives providing support. Practices need committed staff including ENABLE nurse coaches.Check my eligibility
What is being tested?
The study compares two methods of delivering the ENABLE palliative care program: a Virtual Learning Collaborative versus Technical Assistance. It aims to improve quality of life by managing stress, clarifying care goals, and enhancing social and spiritual well-being through various interventions like assessments and educational sessions.See study design
What are the potential side effects?
Since this trial focuses on non-medical interventions such as education and counseling rather than drugs or medical procedures, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics during the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a caregiver and I speak English.
Select...
I was diagnosed with advanced cancer less than 3 months ago.
Select...
I am a nurse or advanced practice provider with oncology or palliative care experience.
Select...
I am an ENABLE nurse coach trained in palliative care assessment.
Select...
I am a licensed nurse with at least 2 years of experience in cancer or palliative care.
Select...
I am willing to do a phone interview for the ENABLE program.
Select...
My nurse coach is trained in palliative care assessments and sessions.
Select...
I have chosen a friend or relative who supports me regularly with my cancer care.
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ENABLE Program Uptake
Secondary outcome measures
Functional Assessment of Chronic Illness-Palliative Care (FACIT-PAL)
Hospital Anxiety and Depression Scale (HADS)
Other outcome measures
Caregiver mood, using the Hospital Anxiety and Depression Scale (HADS).
Caregiver quality of life, Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Global Health
Patient mood, measured by the Hospital Anxiety and Depression Scale (HADS)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Virtual Learning CollaborativeExperimental Treatment1 Intervention
Group II: Technical AssistanceExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Technical Assistance
2019
N/A
~260

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamOTHER
1,583 Previous Clinical Trials
2,279,836 Total Patients Enrolled
University of Rochester NCORP Research BaseLead Sponsor
13 Previous Clinical Trials
8,884 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,459 Total Patients Enrolled

Media Library

ENABLE Palliative Care Program Clinical Trial Eligibility Overview. Trial Name: NCT04062552 — N/A
Solid Tumors Research Study Groups: Virtual Learning Collaborative, Technical Assistance
Solid Tumors Clinical Trial 2023: ENABLE Palliative Care Program Highlights & Side Effects. Trial Name: NCT04062552 — N/A
ENABLE Palliative Care Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04062552 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent have medical facilities adopted this trial?

"The Michigan Cancer Research Consortium, Geisinger Cancer Institute and Prisma Health System are three of the major centres participating in this clinical trial. Additionally, there are 8 other medical facilities located across America that are also taking part in the study."

Answered by AI

To what extent is this experiment being conducted with participants?

"Affirmative. The clinicaltrials.gov database shows that this research initiative, initially posted on July 6th 2021, is currently recruiting patients for participation. 840 volunteers are needed to be sourced from 8 separate testing sites."

Answered by AI

Is recruitment for this research initiative still ongoing?

"This clinical trial is still recruiting, having been originally posted on July 6th 2021 and updated as recently as May 18th 2022. The details are available to view on clinicialtrials.gov."

Answered by AI
~71 spots leftby Sep 2025